For patients with ventricular tachycardia (VT), stereotactic arrhythmia radiotherapy (STAR) may be a comparable and safer alternative to repeat catheter ablation (CA).
A study presented at the annual meeting of the American Society for Radiation Oncology (ASTRO) found that STAR had similar outcomes to CA for high-risk VT.
According to Shannon Jiang, M.D., from the Washington University School of Medicine in St. Louis, STAR may be a comparable and safer alternative to repeat catheter ablation (CA) for patients with ventricular tachycardia (VT).
Author's summary: STAR is a safer alternative to CA for high-risk VT patients.